KILL Platelet BioGenesis Receives $56 Million Contract from the Biomedical Advanced Research and Development Authority (BARDA) to Develop Human Stem Cell-Derived Platelets as a Medical Countermeasure to Radiological and Nuclear Exposure

--(BUSINESS WIRE)-- Platelet BioGenesis requests that their press release NewsItemId: 20190930005207, "Platelet BioGenesis Receives $56 Million Contract from the Biomedical Advanced Research and Development Authority (BARDA) to Develop Human Stem Cell-Derived Platelets as a Medical Countermeasure to Radiological and Nuclear Exposure" issued on September 30th, 2019 be killed.

The release was issued in error by Platelet BioGenesis.

A replacement release will be issued at a later date.